iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson's Disease

被引:32
作者
Badanjak, Katja [1 ]
Mulica, Patrycja [1 ]
Smajic, Semra [1 ]
Delcambre, Sylvie [1 ]
Tranchevent, Leon-Charles [1 ]
Diederich, Nico [2 ]
Rauen, Thomas [3 ]
Schwamborn, Jens C. [1 ]
Glaab, Enrico [1 ]
Cowley, Sally A. [4 ]
Antony, Paul M. A. [1 ,5 ,6 ]
Pereira, Sandro L. [1 ]
Venegas, Carmen [1 ]
Gruenewald, Anne [1 ,7 ]
机构
[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg
[2] Ctr Hosp Luxembourg CHL, Luxembourg, Luxembourg
[3] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany
[4] Univ Oxford, Sir William Dunn Sch Pathol, James Martin Stem Cell Facil, Oxford, England
[5] Univ Luxembourg, Luxembourg Inst Syst Biomed, Dis Modeling & Screening Platform DMSP, Luxembourg, Luxembourg
[6] Luxembourg Inst Hlth, Luxembourg, Luxembourg
[7] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
基金
英国医学研究理事会;
关键词
microglia; iPSC; neuroinflammation; idiopathic Parkinson's disease; disease modeling; SUBSTANTIA-NIGRA; ACTIVATION; NEUROINFLAMMATION; EXPRESSION; METAANALYSIS; ASSOCIATION; LRRK2; LOCI;
D O I
10.3389/fcell.2021.740758
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease (PD) is a neurodegenerative disease with unknown cause in the majority of patients, who are therefore considered "idiopathic" (IPD). PD predominantly affects dopaminergic neurons in the substantia nigra pars compacta (SNpc), yet the pathology is not limited to this cell type. Advancing age is considered the main risk factor for the development of IPD and greatly influences the function of microglia, the immune cells of the brain. With increasing age, microglia become dysfunctional and release pro-inflammatory factors into the extracellular space, which promote neuronal cell death. Accordingly, neuroinflammation has also been described as a feature of PD. So far, studies exploring inflammatory pathways in IPD patient samples have primarily focused on blood-derived immune cells or brain sections, but rarely investigated patient microglia in vitro. Accordingly, we decided to explore the contribution of microglia to IPD in a comparative manner using, both, iPSC-derived cultures and postmortem tissue. Our meta-analysis of published RNAseq datasets indicated an upregulation of IL10 and IL1B in nigral tissue from IPD patients. We observed increased expression levels of these cytokines in microglia compared to neurons using our single-cell midbrain atlas. Moreover, IL10 and IL1B were upregulated in IPD compared to control microglia. Next, to validate these findings in vitro, we generated IPD patient microglia from iPSCs using an established differentiation protocol. IPD microglia were more readily primed as indicated by elevated IL1B and IL10 gene expression and higher mRNA and protein levels of NLRP3 after LPS treatment. In addition, IPD microglia had higher phagocytic capacity under basal conditions-a phenotype that was further exacerbated upon stimulation with LPS, suggesting an aberrant microglial function. Our results demonstrate the significance of microglia as the key player in the neuroinflammation process in IPD. While our study highlights the importance of microglia-mediated inflammatory signaling in IPD, further investigations will be needed to explore particular disease mechanisms in these cells.
引用
收藏
页数:11
相关论文
共 61 条
[1]   FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling [J].
Arias-Fuenzalida, Jonathan ;
Jarazo, Javier ;
Qing, Xiaobing ;
Walter, Jonas ;
Gomez-Giro, Gemma ;
Nickels, Sarah Louise ;
Zaehres, Holm ;
Schoeler, Hans Robert ;
Schwamborn, Jens Christian .
STEM CELL REPORTS, 2017, 9 (05) :1423-1431
[2]   The Contribution of Microglia to Neuroinflammation in Parkinson's Disease [J].
Badanjak, Katja ;
Fixemer, Sonja ;
Smajic, Semra ;
Skupin, Alexander ;
Gruenewald, Anne .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
[3]   Neurodegeneration by Activation of the Microglial Complement-Phagosome Pathway [J].
Bodea, Liviu-Gabriel ;
Wang, Yiner ;
Linnartz-Gerlach, Bettina ;
Kopatz, Jens ;
Sinkkonen, Lasse ;
Musgrove, Ruth ;
Kaoma, Tony ;
Muller, Arnaud ;
Vallar, Laurent ;
Di Monte, Donato A. ;
Balling, Rudi ;
Neumann, Harald .
JOURNAL OF NEUROSCIENCE, 2014, 34 (25) :8546-8556
[4]   Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism [J].
Brodacki, Bogdan ;
Staszewski, Jacek ;
Toczylowska, Beata ;
Kozlowska, Ewa ;
Drela, Nadzieja ;
Chalimoniuk, Malgorzata ;
Stepien, Adam .
NEUROSCIENCE LETTERS, 2008, 441 (02) :158-162
[5]   Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis [J].
Calabrese, Vittorio ;
Santoro, Aurelia ;
Monti, Daniela ;
Crupi, Rosalia ;
Di Paola, Rosanna ;
Latteri, Saverio ;
Cuzzocrea, Salvatore ;
Zappia, Mario ;
Giordano, James ;
Calabrese, Edward J. ;
Franceschi, Claudio .
FREE RADICAL BIOLOGY AND MEDICINE, 2018, 115 :80-91
[6]   Evidence of Inflammatory System Involvement in Parkinson's Disease [J].
Chao, Yinxia ;
Wong, Siew Cheng ;
Tan, Eng King .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[7]   Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease [J].
Collins, Louise M. ;
Toulouse, Andre ;
Connor, Thomas J. ;
Nolan, Yvonne M. .
NEUROPHARMACOLOGY, 2012, 62 (07) :2154-2168
[8]   Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease [J].
Delva, Aline ;
Van Weehaeghe, Donatienne ;
Koole, Michel ;
Van Laere, Koen ;
Vandenberghe, Wim .
MOVEMENT DISORDERS, 2020, 35 (11) :1977-1986
[9]   LRRK2 activation in idiopathic Parkinson's disease [J].
Di Maio, Roberto ;
Hoffman, Eric K. ;
Rocha, Emily M. ;
Keeney, Matthew T. ;
Sanders, Laurie H. ;
De Miranda, Briana R. ;
Zharikov, Alevtina ;
Van Laar, Amber ;
Stepan, Antonia F. ;
Lanz, Thomas A. ;
Kofler, Julia K. ;
Burton, Edward A. ;
Alessi, Dario R. ;
Hastings, Teresa G. ;
Greenamyre, J. Timothy .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
[10]   Familial PD gene involved in idiopathic disease [J].
Fyfe I. .
Nature Reviews Neurology, 2018, 14 (9) :508-508